Pacira BioSciences, Inc.
PCRX
$26.30
$0.311.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.30% | 51.47% | 73.96% | 92.96% | 83.10% |
| Total Receivables | 9.53% | 3.35% | 7.41% | 3.69% | 4.80% |
| Inventory | 43.24% | 38.20% | 20.06% | 15.90% | 12.27% |
| Prepaid Expenses | 86.23% | 46.71% | 0.12% | 28.31% | 20.20% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 42.86% | -- | -- |
| Total Current Assets | 17.94% | 39.93% | 46.11% | 54.27% | 47.26% |
|
|
|||||
| Total Current Assets | 17.94% | 39.93% | 46.11% | 54.27% | 47.26% |
| Net Property, Plant & Equipment | -10.40% | -7.49% | -7.90% | -7.73% | -8.54% |
| Long-term Investments | -87.56% | -86.82% | -- | -- | 0.00% |
| Goodwill | -87.56% | -86.82% | -- | -- | 0.00% |
| Total Other Intangibles | -7.05% | -7.24% | -11.85% | -11.51% | -11.19% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -5.08% | -8.54% | -9.36% | -11.63% | -13.45% |
| Total Assets | -6.65% | 0.21% | -1.33% | -0.83% | 6.77% |
|
|
|||||
| Total Accounts Payable | 60.83% | 157.98% | 21.88% | 17.30% | -22.62% |
| Total Accrued Expenses | 9.58% | 19.83% | 24.76% | 27.54% | 15.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2,217.38% | 1,098.66% | 1,107.79% | 1,120.07% | -67.88% |
| Total Finance Division Other Current Liabilities | -- | -- | 24.43% | -- | -- |
| Total Other Current Liabilities | -- | -- | 24.43% | -- | -- |
| Total Current Liabilities | 237.86% | 236.81% | 218.25% | 227.14% | -14.89% |
|
|
|||||
| Total Current Liabilities | 237.86% | 236.81% | 218.25% | 227.14% | -14.89% |
| Long-Term Debt | -35.84% | -25.48% | -25.35% | -25.21% | 10.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.66% | -16.72% | -18.54% | -16.14% | -16.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 32.59% | 44.21% | -3.17% | -11.81% | 6.44% |
| Total Liabilities | 1.56% | 14.03% | 10.07% | 9.84% | 4.51% |
|
|
|||||
| Common Stock & APIC | 5.33% | 3.44% | 3.36% | 3.45% | 3.42% |
| Retained Earnings | -161.48% | -106.04% | -93.22% | -68.91% | 44.62% |
| Treasury Stock & Other | -185.63% | -15,738.16% | -10,131.58% | -244,330.00% | -14,360.12% |
| Total Common Equity | -13.82% | -10.49% | -10.55% | -9.86% | 8.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.82% | -10.49% | -10.55% | -9.86% | 8.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.82% | -10.49% | -10.55% | -9.86% | 8.82% |
|
|
|||||